DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Dr. Agarwal's Health Care Limited — Outcome of Board Meeting

NSE 3 hrs ago·4 Aug 2026, 8:29 am

DR Agarwals Health Care L

Dr. Agarwal's Eye Hospital has announced the outcome of its recent board meeting. The company has released its consolidated and standalone unaudited financial results for the quarter that ended on June 30, 2026. These results are now available for public review, marking a standard update for investors to assess the hospital's current performance.

For investors, this release is a key data point to evaluate the hospital's operational efficiency and financial health. It provides insight into the company's revenue growth and profitability trends during the quarter. This information is essential for retail investors to gauge the company's trajectory and make informed decisions regarding their holdings.

Investors should closely monitor the key performance indicators, such as revenue growth and net profit margins, presented in the results. Keeping an eye on the management's commentary regarding future growth prospects and operational challenges will also be important for understanding the company's path forward.